Delivery Order SPE2DB22D2206-SPE2DB24FJF56
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FAPM6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,229.79, is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025. This award is not designated as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,839.36 for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $4,306.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of July 23, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a delivery order for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract is a firm fixed-price type, with a period of performance through February 18, 2025. Amerisourcebergen Drug Corp is a for-profit organization that has been registered in the System for Award Management (SAM.gov) since...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FXWH0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,580.53 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a major pharmaceutical distributor that plays a critical role in supplying medical...
This federal contract award, identified as SPE2DB22D1200|SPE2DB25FM9BJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,583.28, is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a multiple sclerosis medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 20, 2024. Amerisourcebergen Drug Corp, the prime...
This federal contract award, valued at $2,474.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The period of performance runs through September 27, 2024. The contract is not set aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,289.18 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of COPAXONE 40 MG/ML SYRINGEML. The contract is a Delivery Order with a Firm Fixed Price of $2,929.12 and an ultimate completion date of April 4, 2025. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...